Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kevan Zapolnik
Observed name:
K. Zapolnik
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
ORCID:
0000-0001-8153-8352
Observed ORCID:
0000-0001-8153-8352
OpenAlex ID:
A5000566240
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia
2021
·
Swagata Goswami
, Rajeswaran Mani
, et al.
·
Blood
·
44
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia
2021
·
Eileen Y. Hu
, Priscilla Do
, et al.
·
Blood Advances
·
32
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia
2020
·
Rajeswaran Mani
, Girish Rajgolikar
, et al.
·
Cytotherapy
·
19
Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
2022
·
Max Yano
, Chia Sharpe
, et al.
·
Blood Advances
·
14
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling
2019
·
J. T. Greene
, Rajeswaran Mani
, et al.
·
Blood Advances
·
11
PDF
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity
2022
·
Chi-Ling Chiang
, Eileen Y. Hu
, et al.
·
Cell Reports
·
7
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia
2022
·
Swagata Goswami
, Chi-Ling Chiang
, et al.
·
Leukemia Research
·
3
PDF
ROR1 Targeted Immunoliposomal Delivery of OSU-2S Show Selective Cytotoxicity in t(1;19) Translocated B-ALL
2019
·
Swagata Goswami
, Chi-Ling Chiang
, et al.
·
Blood
·
1
The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages
2018
·
Eileen Hu
, Jessica Waibl-Polania
, et al.
·
Blood
·
1
OSU-2S, a Novel PKC Activator, Mediates PKC Dependent Cell Death, Differentiation and Cell Cycle Arrest in Acute Myeloid Leukemia
2017
·
Swagata Goswami
, Rajeswaran Mani
, et al.
·
Blood
·
1
To Catch a Killer: Delineating the Mechanistic Role of Siglec-6, a Novel Glycoprotein Target, for the Treatment of Chronic Lymphocytic Leukemia
2022
·
Jessica Nunes
, Ann Ventura
, et al.
·
Blood
Delineating the mechanistic pathway and therapeutic potential of Siglec-6 in Chronic Lymphocytic Leukemia
2022
·
Jessica Judith Nunes
, Ann Ventura
, et al.
·
The Journal of Immunology
Defining the Biochemical Role of Sialic Acid-Binding Immunoglobulin-like Lectin-6 in Adhesion and Migration in Chronic Lymphocytic Leukemia
2021
·
Jessica Nunes
, Ann Ventura
, et al.
·
Blood
Defining the role of Siglec-6-DOCK8 axis in cell adhesion and migration in Chronic Lymphocytic Leukemia
2021
·
Jessica Judith Nunes
, Ann Ventura
, et al.
·
The Journal of Immunology
Evaluation of membrane bound IL-21 expanded natural killer cells for chronic lymphocytic leukemia therapy
2021
·
Max Yano
, J Rachel Lance
, et al.
·
The Journal of Immunology
Fc engineered anti-CD33mAb potentiates cytotoxicity of mbIL-21 expanded NK-cells against primary AML pre-treated with decitabine
2019
·
R. Mani
, G. Rajgolikar
, et al.
·
Cytotherapy
Show more works
View as search
Works count:
16
Citation count:
133
H-index:
6
I10-index:
5
Year
Topic
Type